Compare FTK & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FTK | AORT |
|---|---|---|
| Founded | 1985 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 937.2M | 946.5M |
| IPO Year | 1997 | 1996 |
| Metric | FTK | AORT |
|---|---|---|
| Price | $24.57 | $18.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 9 |
| Target Price | ★ $39.42 | $38.47 |
| AVG Volume (30 Days) | 270.8K | ★ 703.7K |
| Earning Date | 11-03-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 147.06 | ★ 165.62 |
| EPS | ★ 0.72 | N/A |
| Revenue | $136,092,000.00 | ★ $298,836,000.00 |
| Revenue This Year | $62.65 | $10.91 |
| Revenue Next Year | $11.85 | $11.06 |
| P/E Ratio | $34.50 | ★ N/A |
| Revenue Growth | ★ 214.53 | 18.01 |
| 52 Week Low | $13.19 | $18.12 |
| 52 Week High | $39.67 | $48.25 |
| Indicator | FTK | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 46.82 | 32.51 |
| Support Level | $21.45 | N/A |
| Resistance Level | $25.39 | $24.74 |
| Average True Range (ATR) | 1.89 | 1.45 |
| MACD | 0.12 | -0.47 |
| Stochastic Oscillator | 35.44 | 2.08 |
Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.